GlassScriptPhysician profile
Heather Mink
NPI 1417596230
$500.38
in general payments reported to CMS, 2019-2025
11 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.73 · 2023: $97.79 · 2024: $124 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $128.15 | 2025 | Veozah |
| Biogen, INC. | $120.73 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $57.53 | 2022-2024 | Third Wave, Thinprep 2000 Processor, Aptima |
| Axonics, INC. | $54.72 | 2023 | Axonics, Bulkamid |
| Exeltis, USA INC. | $30.72 | 2024 | Slynd |
| Organon LLC | $28.86 | 2023-2024 | Nexplanon |
| Daiichi Sankyo INC. | $22.02 | 2024 | Injectafer |
| Vertex Pharmaceuticals Incorporated | $16.79 | 2025 | |
| Merck Sharp & Dohme LLC | $15.43 | 2023 | Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $14.09 | 2023 | |
| Amgen INC. | $11.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Mink listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.